Michael E. Goldberg
13Patents
4h-index
11Co-inventors
53Inventor score
Filing activity: Mar 13, 1998 → Nov 2, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6099851A | Therapeutic uses of leuprolide acetate | Human Necessities | 101 | Expired |
| US6479063B2 | Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis | Human Necessities | 31 | Expired |
| US9650352B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 19 | Active |
| US9867830B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 9 | Active |
| US7856498B2 | Collaborative alert management and monitoring | Physics | 3 | Active |
| US6534537B2 | Use of HMG-COA reductase inhibitors to prevent and treat BPH | Human Necessities | 2 | Expired |
| US6140315A | Therapeutic uses of goserelin acetate | Human Necessities | 2 | Expired |
| US6197337A | Therapeutic uses of abarelix | Human Necessities | 2 | Expired |
| US6090409A | Therapeutic uses of finasteride | Human Necessities | 1 | Expired |
| US6630164B2 | Dutasteride to prevent and treat atherosclerosis | Human Necessities | 0 | Expired |
| US6627227B2 | Use of saw palmetto to prevent atherosclerosis | Human Necessities | 0 | Expired |
| US7528172B2 | Compositions and methods for improving recovery after general anesthesia | Human Necessities | 0 | Expired |
| US7169768B1 | Method of decreasing atherosclerosis and its complications | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.